Aligos Therapeutics Stock Forecast

ALGS's stock price has decreased by -61.25% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Aligos Therapeutics stock have an average target of 60, with a low estimate of 50 and a high estimate of 70. The average target predicts an increase of 500.60% from the current stock price of 9.99.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$50	$60	$70	$70
Change	+400.50%	+500.60%	+600.70%	+600.70%

* Price targets were last updated on Sep 12, 2025.

Analyst Ratings

The average analyst rating for Aligos Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	1	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick R. Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $50	Strong Buy	Reiterates	$50	+400.50%	Sep 12, 2025
Patrick R. Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $50	Strong Buy	Initiates	$50	+400.50%	Aug 18, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $70	Strong Buy	Reiterates	$70	+600.70%	Mar 31, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $75 → $70	Strong Buy	Maintains	$75 → $70	+600.70%	Mar 11, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $75	Strong Buy	Reiterates	$75	+650.75%	Nov 7, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

2.73M

from 3.95M

-30.70%

from 3.95M

Revenue Next Year

2.17M

from 2.73M

-20.70%

from 2.73M

EPS This Year

-8.33

from -20.94

EPS Next Year

-7.42

from -8.33

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	4.36M	13.91M	15.53M	3.95M	2.73M	2.17M
Revenue Growth	-	-	219.04%	11.66%	-74.60%	-30.70%	-20.70%
EPS	-271.68	-80.50	-56.25	-34.20	-20.94	-8.33	-7.42
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	3.6M	4.7M
Avg	2.7M	2.2M
Low	2.0M	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-9.5%	72.8%
Avg	-30.7%	-20.7%
Low	-50.3%	-

EPS Forecast

EPS	2025	2026
High	-7.99	-5.21
Avg	-8.33	-7.42
Low	-8.87	-8.53

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.